Norwich Pharmaceuticals commits $20,000 to Chenango Memorial campaign

Chenango’s oldest pharmaceuticals manufacturer has committed $20,000 toward a new emergency room and walk-in center at UHS Chenango Memorial Hospital.

Officials from Norwich Pharmaceuticals, an Alvogen Company, presented a ceremonial check to campaign leaders at the company’s North Norwich facility this week. The pledge is the latest corporate commitment to be announced in the capital campaign, which kicked off in August.

“On behalf of Norwich Pharmaceuticals and all its employees, I am excited to be able to share our pledge of $20,000 toward UHS Chenango Memorial’s capital campaign,” said Brian Reid, Vice President of Operations at Norwich.

The North Norwich manufacturer, which traces its roots to the Norwich Pharmacal Company, has a workforce of approximately 300 and a long history in Chenango County.

“Quality healthcare in Chenango County is essential to our employees and their families. We are extremely grateful to UHS Chenango Memorial for their commitment toward improving the quality of life for all residents of the greater Chenango County community,” Reid said.

Dr. Drake Lamen, President and CEO of UHS Chenango Memorial, thanked Reid and his leadership team for their commitment to the hospital and community.

“We are incredibly grateful for Norwich Pharmaceutical’s support and leadership,” Lamen said. “They are an organization truly committed to both organizational excellence and making this community a better place.”

He specifically thanked HR Director Ric Festarini for his service on the UHS Chenango Memorial Board of Directors, as well as HR Manager Luke Murphy for his work on the hospital’s Campaign Cabinet and his role in organizing Alvogen Day. The hospital is one of more than two dozen nonprofits which benefit from the service of Alvogen volunteers during this company-wide day of community service each September.

According Lamen, the pharmaceutical company’s gift brings the hospital closer to the capital campaign’s $3.5 million fundraising threshold.

The campaign, announced at the grand opening of the facility’s new Cardiology and Cardiac Rehabilitation Center in August, will support construction of a new Emergency Room and Walk-In Center, as well as strategic investments in Diagnostic Imaging and infrastructure to support the growth of future services. The work is part of the first phase of the hospital’s Chenango Medical Neighborhood Plan, which will transform the delivery of care at UHS Chenango Memorial.

“This is the largest concentrated investment in our facility in more than 50 years,” Lamen said. “The funds we raise with the campaign will help ensure we can leverage both the state funding we are receiving and our own resources to fully realize our vision for this project.”

For more information on the 2019 Chenango Medical Neighborhood Capital Campaign, contact Melissa Stagnaro, Director of Fundraising and Business Development at UHS Chenango Memorial, at (607) 337-4183 or via email at melissa.stagnaro@nyuhs.org.

Norwich Pharmaceuticals is a division of Alvogen, a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, over-the-counter (OTC) and biosimilar products for patients around the world. With a commercial footprint in over 35 markets, Alvogen’s key regions include the US and emerging markets in the Central and Eastern European (CEE) and Asia Pacific (APAC) regions. Alvogen carries on the history and legacy of Norwich Pharmaceuticals, founded in Norwich in 1887, and continues to operate in Chenango County, employing 300 people.

UHS Chenango Memorial Hospital is a member of United Health Services, a locally owned not-for-profit 916-bed hospital and health care system serving the Greater Binghamton region from more than 40 locations around New York’s Southern Tier.